An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference57 articles.
1. Emerging options in multiple myeloma: targeted, immune, and epigenetic therapies;Kumar;Hematology (Am. Soc. Hematol. Educ. Program),2017
2. Emerging drugs and combinations to treat multiple myeloma;Larocca;Oncotarget,2017
3. Molecular targets for the treatment of multiple myeloma;Rossi;Curr. Cancer Drug Targets,2012
4. Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma;Amodio;Expert Opin. Biol. Ther.,2013
5. Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities;Botta;Front. Oncol.,2014
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnostic application of aptamers against leukemia, multiple myeloma and lymphoma: A review;Journal of Drug Delivery Science and Technology;2024-10
2. Advances in MicroRNA Therapeutics: from Preclinical to Clinical Studies;Human Gene Therapy;2024-08-16
3. Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions;Pharmaceuticals;2024-06-25
4. Modified nucleic acid aptamers: development, characterization, and biological applications;Trends in Biotechnology;2023-11
5. Functional Study of Conjugate of VASN Aptamer-DNAzyme for Telomerase Reverse Transcriptase;PROG BIOCHEM BIOPHYS;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3